Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $5.37, $0.25 better than the analyst estimate of $5.12. Revenue for the quarter came in at $10.54 billion versus the consensus estimate of $10.5 billion.

GUIDANCE:

Thermo Fisher Scientific sees FY2024 EPS of $21.29-$22.07, versus the consensus of $21.70. Thermo Fisher Scientific sees FY2024 revenue of $42.4-43.3 billion, versus the consensus of $42.96 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.